Laura Lanotte
Barletta, 70051, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Early first-line systemic anticancer therapeutic attrition after metastatic recurrence in triple-negative breast cancer following neoadjuvant chemo-immunotherapy: a multicenter real-world study.
Journal: Breast cancer research and treatment
Published: March 26, 2026
Cancer-Induced Neuropathic Pain: Clinical Features and Treatment Options.
Journal: Cureus
Published: December 16, 2025
BRCA1 and 2 Mutations and Efficacy of Pembrolizumab-Based Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Real-World Multicenter Analysis.
Journal: Journal of clinical medicine
Published: November 12, 2025
Impact of Chemotherapy Dose Intensity on Pathological Complete Response in Pembrolizumab-Treated Early Triple-Negative Breast Cancer: A Real-World Multicenter Analysis.
Journal: Cancers
Published: September 18, 2025
Use of Dexmedetomidine as an Adjuvant in Spinal Anesthesia in Patients With Femoral Fracture Affected by Moderate Aortic Stenosis: A Case Series.
Journal: Cureus
Published: April 29, 2025
Metronomic chemotherapy and breast cancer: a critical evaluation of its role in the new landscape of therapeutics.
Journal: Expert opinion on drug safety
Published: October 18, 2024
Evaluating CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: A Retrospective Real-World Multicenter Study.
Journal: Cancers
Published: September 13, 2024
Synergizing Immunotherapy and Antibody-Drug Conjugates: New Horizons in Breast Cancer Therapy.
Journal: Pharmaceutics
Published: August 13, 2024
Last Updated: 09/26/2026